U.S. markets open in 7 hours 24 minutes

Intellipharmaceutics: Fiscal 4Q Earnings Snapshot

TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCIF) on Friday reported a loss of $1.3 million in its fiscal fourth quarter.

The Toronto-based company said it had a loss of 4 cents per share.

The extended-release drug developer posted revenue of $232,500 in the period. Its adjusted revenue was $233,000.

For the year, the company reported that its loss narrowed to $8.1 million, or 37 cents per share. Revenue was reported as $3.5 million.

In the final minutes of trading on Friday, the company's shares hit 12 cents. A year ago, they were trading at 31 cents.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IPCIF at https://www.zacks.com/ap/IPCIF